Abstract：
:This paper reconsiders the evidence and several of the key arguments associated with the theory of supplier-induced demand (SID). It proposes a new theory to explain how ethical behaviour is consistent with SID. The purpose of a theory of demand and one criterion for the evaluation of a theory is the provision of a plausible explanation for the observed variability in service use. We argue that Australian data are not easily explained by orthodox possible explanation. We also argue that, having revisited the theory of SID, the agency relationship between doctors and patients arises not simply because of asymmetrical information but from an asymmetrical ability and willingness to exercise judgement in the face of uncertainty. It is also argued that the incomplete demand shift that must occur following an increase in the doctor supply is readily explained by the dynamics of market adjustment when market information is incomplete and there is non-collusive professional (and ethical) behaviour by doctors. Empirical evidence of SID from six Australian data sets is presented and discussed. It is argued that these are more easily explained by SID than by conventional demand side variables. We conclude that once the uncertainty of medical decision making and the complexity of medical judgements are taken into account, SID is a more plausible theory of patient and doctor behaviour than the orthodox model of demand and supply. More importantly, SID provides a satisfactory explanation of the observed pattern and change in the demand for Australian medical services, which are not easily explained in the absence of SID.
journal_name
Appl Health Econ Health Policyjournal_title
Applied health economics and health policyauthors
Richardson JR,Peacock SJdoi
10.2165/00148365-200605020-00003subject
Has Abstractpub_date
2006-01-01 00:00:00pages
87-98issue
2eissn
1175-5652issn
1179-1896pii
523journal_volume
5pub_type
杂志文章,评审abstract：BACKGROUND:Limited empirical evidence exists regarding the effect of price changes on hospital behavior and, ultimately, the quality of care. Additionally, an overview of the results of prior literature is lacking. OBJECTIVE:This study aims to provide a synthesis of existing research concerning the relationship betwee...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/s40258-020-00577-6
更新日期：2020-10-01 00:00:00
abstract：:The rapid rise in pharmaceutical costs in France has been driven by new technologies and the growing prevalence of chronic diseases as well as considerable prescribing freedom and choice of physician among patients. This has led to the introduction of a number of reforms and initiatives in an attempt to moderate expen...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/BF03256162
更新日期：2010-01-01 00:00:00
abstract：BACKGROUND:Patients with venous thromboembolism (VTE) commonly have an underlying genetic predisposition. However, genetic tests nowadays in use have very low sensitivity for identifying subjects at risk of VTE. Thrombo inCode(®) is a new genetic tool that has demonstrated very good sensitivity, thanks to very good cov...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-015-0153-x
更新日期：2015-04-01 00:00:00
abstract：:The debate surrounding whether the findings of efficacy studies are applicable to real-world treatment situations is ongoing. The issue of lack of applicability due to a lack of clinical heterogeneity could be addressed by employing less restrictive inclusion criteria. Given that health economic assessments based on c...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.2165/11590150-000000000-00000
更新日期：2011-05-01 00:00:00
abstract：BACKGROUND:Community-based health insurance (CBHI) schemes have been introduced in low- and middle-income countries to increase health service utilization and provide financial protection from high healthcare expenditures. OBJECTIVE:We assess the impact of household size on decisions to enroll in CBHI and demonstrate ...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-016-0222-9
更新日期：2016-04-01 00:00:00
abstract：:In Germany, the Institute for Quality and Efficiency in Health Care (IQWiG) makes recommendations for ceiling prices of drugs based on an evaluation of the relationship between costs and effectiveness. To set ceiling prices, IQWiG uses the following decision rule: the incremental cost-effectiveness ratio (ICER) of a n...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.2165/11586640-000000000-00000
更新日期：2011-03-01 00:00:00
abstract：:The first objective of this paper is to expound the particular challenge posed by the occurrence of inconsistency in the expression of preferences by mental health patients to both economists and policy makers. Since this difficulty cannot be resolved, the second aim of the paper is to identify agents who may be count...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-019-00479-2
更新日期：2020-04-01 00:00:00
abstract：BACKGROUND:Response to growth hormone (GH) therapy may vary between individual patients. Therefore the use of GH in children should be closely monitored to avoid over, under, or ineffective treatment regimens. The treatment response can be evaluated using growth prediction models. In an effort to improve the accuracy o...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-013-0030-4
更新日期：2013-06-01 00:00:00
abstract：:Virtual Touch™ Quantification (VTq) is a software application used with Siemens Acuson ultrasound scanners to assess the stiffness of liver tissue. The National Institute for Health and Care Excellence (NICE) Medical Technologies Advisory Committee (MTAC) selected VTq for evaluation and invited the company to submit c...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/s40258-016-0277-7
更新日期：2017-04-01 00:00:00
abstract：OBJECTIVES:To describe how post-market utilisation analysis in Australia informs cost-effectiveness assessment and pricing decisions, using aflibercept and ranibizumab as case studies. METHODS:Pharmaceutical claims were used to identify initiators of aflibercept and ranibizumab in the year after aflibercept-listing (D...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-018-0440-4
更新日期：2019-06-01 00:00:00
abstract：:Central venous catheters are commonly used to deliver therapies and to monitor patients, and require securing at the point of percutaneous entry to avoid dislodgement. SecurAcath is a catheter securement device designed for central venous catheters. The National Institute for Health and Care Excellence, as a part of i...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/s40258-018-0427-1
更新日期：2018-12-01 00:00:00
abstract：BACKGROUND:The Xpert® MTB/RIF (Xpert) test has been shown to be effective and cost-effective for diagnosing tuberculosis (TB) under conditions with high HIV prevalence and HIV-TB co-infection but less is known about Xpert's cost in low HIV prevalence settings. Cambodia, a country with low HIV prevalence (0.7%), high TB...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-018-0397-3
更新日期：2018-08-01 00:00:00
abstract：:Blockchain technology is a decentralized database that stores a registry of assets and transactions across a peer-to-peer computer network, which is secured through cryptography, and over time, its history gets locked in blocks of data that are cryptographically linked together and secured. So far, there have been use...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-018-0412-8
更新日期：2018-10-01 00:00:00
abstract：BACKGROUND AND OBJECTIVE:Opinions on the use of research abstracts in policy decision making are conflicting. We sought to evaluate the influence of research abstracts in guiding decisions of the Joint Oncology Drug Review of Canada (JODR), which conducts clinical and economic reviews of new cancer treatment drugs for ...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.2165/11530510-000000000-00000
更新日期：2010-01-01 00:00:00
abstract：:There is wide consensus that the ways in which providers are reimbursed by third parties will affect their behaviour and, hence, the efficient use of limited resources and the performance of health systems. However, there seems to be little evidence on how payment to hospital-based doctors affects hospital performance...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：
更新日期：2003-01-01 00:00:00
abstract：BACKGROUND:Chronic obstructive pulmonary disease (COPD) affects approximately 3 million people in the UK. An 8-week pulmonary rehabilitation (PR) course is recommended under current guidelines. However, studies show that initial benefits diminish over time. OBJECTIVE:We present here an economic evaluation conducted al...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,随机对照试验
doi：10.1007/s40258-015-0199-9
更新日期：2016-02-01 00:00:00
abstract：OBJECTIVES:The objective of the present work was to assess the level of evidence in economic evaluations of percutaneous left atrial appendage closure devices, and to test the complementarity of three different tools for assessing the quality of economic evaluations. METHODS:We conducted a systematic review of article...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-018-0429-z
更新日期：2018-12-01 00:00:00
abstract：:The South Korean Government recently announced a reform in the drug anti-rebate law, with the purpose of eradicating pervasive, unethical, and illegal rebate practices in pharmaceutical marketing. The main objective of this reform is to have the ability to bring criminal charges against doctors and pharmacists for rec...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/s40258-013-0029-x
更新日期：2013-08-01 00:00:00
abstract：AIM:To assess the relative cost effectiveness of four strategies (academic detailing, computerised reminder systems, target payments and interactive continuing medical education) to increase the provision of screening and brief interventions by Australian GPs with the ultimate goal of decreasing risky alcohol consumpti...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.2165/00148365-200605030-00002
更新日期：2006-01-01 00:00:00
abstract：BACKGROUND:Canadian patients, healthcare providers and payers share interest in assessing the value of self-monitoring of blood glucose (SMBG) for individuals with type 2 diabetes but not on insulin. Using the UKPDS (UK Prospective Diabetes Study) model, the Canadian Optimal Prescribing and Utilization Service (COMPUS)...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.2165/11594270-000000000-00000
更新日期：2011-11-01 00:00:00
abstract：CONTEXT:The in-hospital costs of extracorporeal membrane oxygenation (ECMO) have not been well established. OBJECTIVE:To evaluate the in-hospital costs of ECMO technology in both US and non-US settings for all patient types. DATA SOURCES:Systematic review of English-language articles, using the PubMed, Embase, Web of...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/s40258-015-0170-9
更新日期：2015-08-01 00:00:00
abstract：INTRODUCTION:From 2000 to 2004, primary care organisations (PCOs) in England were legally required to operate a prescribing incentive scheme for their general practices. A statutory framework specified the types of target, maximum rewards and use of 'good cause for failure' provisions that schemes should include. Our o...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.2165/00148365-200504020-00005
更新日期：2005-01-01 00:00:00
abstract：OBJECTIVE:Several EU countries are determining reimbursement prices of pharmaceuticals by cross-referencing prices of foreign countries. Our objective is to quantify the theoretical cross-border spill-over effects of cross-reference pricing schemes on pharmaceutical prices in the former EU-15 countries. METHODS:An ana...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.2165/00148365-200605040-00005
更新日期：2006-01-01 00:00:00
abstract：:This article reviews the concept of costing, and how cost data have been considered and reported in recent multinational economic evaluations. It appears that current practice frequently does not comply with microeconomic foundations and standards for good practice. A number of studies fail to indicate the year of cos...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：
更新日期：2003-01-01 00:00:00
abstract：:This paper critically evaluates the estimates of the cost of Medicare for All (M4A) in the USA. Six studies that estimate the 1-year total cost of M4A in the USA are reviewed. These studies find that M4A would increase national health spending by as much as 16.9% or decrease it by 20.0%, representing a range of estima...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-021-00636-6
更新日期：2021-01-25 00:00:00
abstract：BACKGROUND:This research seeks to identify the relationship between economic factors related to the ability to receive and pay for health services and adverse cancer outcomes, as well as preventative screening and behavioral factors that influence the risk of cancer. We focus on the Northern High Plains region, where w...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-014-0099-4
更新日期：2014-08-01 00:00:00
abstract：BACKGROUND:The management of the large patient population in Italy receiving long-term oral anticoagulation therapy (OAT) poses organizational challenges that are traditionally approached with a centralized procedure, relying on hospital-based clinics and/or GPs. However, the availability of near-patient testing device...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.2165/11313890-000000000-00000
更新日期：2010-01-01 00:00:00
abstract：:The Peristeen transanal irrigation system is intended to allow people with bowel dysfunction to flush out the lower part of the bowel as part of their bowel management strategy. Peristeen was the subject of an evaluation by the National Institute for Health and Care Excellence, through its Medical Technologies Evaluat...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/s40258-018-0447-x
更新日期：2019-02-01 00:00:00
abstract：:The biotech industry now accounts for a substantial and growing proportion of total R&D spending on new medicines. However, compared with the pharmaceutical industry, the biotech industry is financially fragile. This article illustrates the financial fragility of the biotech and pharmaceutical industries in the US and...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/BF03256149
更新日期：2009-01-01 00:00:00
abstract：:The mandatory nature of recommendations made by the National Institute for Health and Clinical Excellence (NICE) in the UK has highlighted inherent difficulties in the process of disinvestment in existing technologies to fund NICE-approved technologies. A lack of evidence on candidate technologies means that the proce...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/BF03256137
更新日期：2009-01-01 00:00:00
